Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

HOLD

Why is it flat despite impressive metrics? Yes, he's frustrated too. Why is it flat? MFC remains a show-me story. MFC needs to right the ship in annuities. True, Asia is their growth engine, but MFC needs a higher yield curve; rates are flat or lowering. So, this hurts all lifecos as well as banks. That said, MFC pays a good dividend and it's cheap, so he continues to hold it. Over time, investors will get rewarded, but until then, you will be rewarded by that dividend. MFC is pushing its investment service. Also, they will bring their asset management expertise in India in a new joint venture and this will let them pick up more assets to manage and develop into a new growth engine in the next 20 years.

Wealthica Track your Stocks in your Watch List

WAIT

Do you see it reaching $30 in 12 months? A good question. This company does well with interest rates low. See if can break the neckline in the mid-$20s to see if it can get to $30.

BUY

Pros and cons. Yes, they won the trial, but there remains a litigation overhang (they should win their appeal). They just had a good quarter, but it was driven by Asia--is this sustainable? He expects 9% EPS growth and 10% annual dividend growth. Trades around 7x. It's outstanding value, but all insurance companies are hurt by falling interest rates. MFC has done a great job diversifying away from that, though.

BUY

He got concerned with the lawsuit, sold and bought SLF instead, but there's nothing wrong with MFC. He has shifted away from insurance to REITs, because the latter will benefit when interest rates are cut. You will do fine with MFC in the long term. Pay a 4.3% dividend, so you're paid to wait. This should drift a little higher. The valuation is reasonable, about 1x book.

COMMENT

She likes this holding in their portfolio and it trades at 1 times book. A trade deal between China and the US will be positive for the market as a whole. She is not sure it will make more than a market like improvement as their business is not focused on goods going in or out of China.

PAST TOP PICK

(A Top Pick May 25/18, Down 3%) Excellent quarter. Asia very good. Japan great. At book value and less than 10 times earnings.

TOP PICK

Above its long-term support line of $22. History of breaking the 200 day moving average, but always bounces back. Take advantage of the short-term weakness. Yield is 4.3%.

COMMENT

Upside potential with exposure to Asian market? Not expensive trades a 9-10X earnings, 4.1% dividend yield. Asian franchise has been fantastic and growing but hasn't offset their terrible U.S. franchise which has been depressing their return on equity. Has grown the asset under management business globally but has had some net outflows on the asset management side. Great chance to grow the Asian franchise, has a great brand name in Asia. Not expensive, nice dividend.

HOLD

Preferreds are a hold or sell? The preferreds have been terrible performers as the resets are lower because interest rates have been lower. He doesn't like resets but they are doing OK now. Manulife got good results.

BUY

vs. the Canadian banks It's not an either-or question. You can buy both. The new CEO has done a very good job to put aside the legacy businesses that are a drag. They have high-growth insurance business in Asia. MFC has lagged SLF the past few years in terms of stock price, but MFC's earnings should outpace SLF's. Also, MFC is closer to book value than SLF. It pays a good dividend. The banks are attractively priced too.

WAIT

The word hope is always mentioned with MFC as in hoping the price rises to $30. That said, MFC is Scotiabank's top insurance pick. It's the only one to exceed EPS expectations. All Canadian insurers need the markets to do better and be less volatile. MFC's wealth management had outflows of $9 billion last quarter; this quarter only $1 billion which is good. EPS grew 20% in the last quarter. He will wait till MFC breaks out of its 10-year trendline.

COMMENT

It scores well on valuation -- 99 percentile. Only 9 times PE. Good yield which is safe. An interest rate cut would hurt their margins and possibly their share price. Without global growth turning around yet, rates could come under pressure. Yield 4%

BUY

Why hasn't it taken off? He loves it this year, outperforming the banks. He sees great upside. They're buying back a lot of shares. That lawsuit overhang is gone. It's trading below historical valuation.

WEAK BUY

He has a small position. He lightened it in the past. He would buy on a pullback. Asia looks promising. We have not seen a whole lot of growth out of their Asia operations so far, however. He has difficulty with their growth model otherwise. (Analysts’ price target is $29.00)

COMMENT

Their bet on Asia paid off. One of the major headwinds is interest rates. Over ten years you were just clipping the dividend. If you think interest rates are headed higher then you would be more bullish or if you agree with him that they are going lower then you would stay away. (Analysts’ price target is $28.58)

Showing 391 to 405 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)